{
  "author": "plausiblyacat",
  "the_new_excerpt": "Anyone else feeling bullish on PSY?\n\nThe first psychedelic medicine ETF to be listed in the US. Top holdings include\nmedical psychedelics, ketamine, and cannabis stocks. I’d been wanting to invest\nin Charlottes Web but it wasn’t available on my platforms and PSY holds it!\n\nInvestor Place article…",
  "original_created_utc": 1623104809,
  "localize": [
    {
      "locale": "ja",
      "the_new_excerpt": "PSYに強気になっている人はいませんか？\n\n米国で初めて上場したサイケデリック薬のETFです。上位保有銘柄は\n医療用サイケデリック、ケタミン、大麻の銘柄が上位を占めています。投資したいと思っていた\nCharlottes Webに投資したいと思っていましたが、私のプラットフォームでは利用できず、PSYがそれを保持しています\n\nインベスタープレイスの記事...",
      "title": "初のサイケデリック医薬品 ETF：PSY"
    },
    {
      "locale": "zh",
      "the_new_excerpt": "还有人觉得看涨PSY吗？\n\n第一个在美国上市的迷幻药ETF。主要持股包括\n医用迷幻药、氯胺酮和大麻股票。我一直想投资\n但在我的平台上没有，而PSY持有它！我一直想投资Charlottes Web。\n\n投资者广场的文章...",
      "title": "第一个迷幻药ETF: PSY"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "還有人覺得看漲PSY嗎？\n\n第一個在美國上市的迷幻藥ETF。主要持股包括\n醫用迷幻藥、氯胺酮和大麻股票。我一直想投資\n但在我的平臺上沒有，而PSY持有它！我一直想投資Charlottes Web。\n\n投資者廣場的文章...",
      "title": "第一個迷幻藥ETF: PSY"
    }
  ],
  "title": "First Psychedelic Med ETF: PSY",
  "created_utc": 1623132412,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>Anyone else feeling bullish on PSY?</p>\n\n<p>The first psychedelic medicine ETF to be listed in the US. Top holdings include medical psychedelics, ketamine, and cannabis stocks. I’d been wanting to invest in Charlottes Web but it wasn’t available on my platforms and PSY holds it! </p>\n\n<p>Investor Place article shared details to know about it: </p>\n\n<p>PSY is the first psychedelic stocks ETF.\nWhile it’s the first, it hasn’t been around for long.\nThe ETF was only just set up at the end of May.\nPSY’s focus is on investing in psychedelic stocks that can be used to treat mental illnesses.\nThat includes depression, which it points out is a growing problem.\nThat comes from claims that as many as 30% of depression patients aren’t responding to current treatments.\nIt also says that research budgets for psychiatric medicine have declined by 70% at large companies.\nPSY believes that this presents an opportunity for new treatments making use of psychedelic treatments to meet growing demand.\nThese treatments could potentially be used for those suffering from “anxiety, PTSD, OCD, eating disorders, depression” and more.\nThe ETF says that it looks to track the BITA Medical Psychedelics, Cannabis, and Ketamine Index.\nIt mentions that companies in the index must have a market cap of at least $75 million.\nThey must also be connected to the medical psychedelics, medical cannabis, or ketamine industries in some way.\nIts top holdings include Charlottes Web (OTCMKTS:CWBHF), Aurora Cannabis (NASDAQ:ACB), Cronos Group (NASDAQ:CRON), Corbus Pharmaceuticals (NASDAQ:CRBP), and Supreme Cannabis.</p>\n\n<p>Edit: added thats it’s the first one to be listed in the US (not the first globally).</p>\n</div><!-- SC_ON -->",
  "score": 60,
  "permalink": "/r/stocks/comments/nupg4f/first_psychedelic_med_etf_psy/",
  "subreddit": "stocks",
  "id": "nupg4f",
  "is_self": true,
  "media": null,
  "is_video": false,
  "source_updated_at": 1623404888028
}